NEJM challenge seeks to demonstrate clinical trial data sharing's potential

By Melissa Fassbender

- Last updated on GMT

(Image: iStock/anyaberkut)
(Image: iStock/anyaberkut)

Related tags Clinical trial data Health care

Clinical trial data sharing continues to be a contentious topic in the industry, so in an attempt to demonstrate its potential, the New England Journal of Medicine (NEJM) is sponsoring the SPRINT Data Analysis Challenge.

Over recent years, many questions have arisen as to who owns clinical trial data, putting the issue of data sharing at a critical turning point​,” NEJM editor-in-chief Dr. Jeffrey Drazen, told in a statement.

The SPRINT Data Analysis Challenge​ tasks individuals and groups to identify a novel scientific or clinical result after analyzing the dataset underlying the SPRINT article​: A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

The challenge culminates with the Aligning Incentives for Sharing Clinical Trial Data summit in April.

“We believe this will be the start of an ongoing conversation among the three key constituencies – clinical trialists, data analysts, and patient participants — to whom data matters most​,” said Drazen.

The community has an opportunity to shape the future of clinical trial data sharing, and the SPRINT Challenge is a step toward that goal,​” he added.

Isaac Kohane, M.D. Ph.D., Chair of Harvard Medical School’s Department of Biomedical Informatics and Co-Chair of the SPRINT Challenge described the challenge as “a catalyst for a new framework for data sharing​.”

The challenge is open to health care professionals, researchers, and scientists.

Related news

Show more

Related products

show more

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Content provided by Formedix | 17-Apr-2023 | White Paper

Companies often have to conduct multiple clinical trials at the same time, which means they've got to be efficient, and compliant with industry regulations....

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Content provided by Elligo Health Research® | 13-Apr-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

A Guide Through the API Drug Development Pipeline.

A Guide Through the API Drug Development Pipeline.

Content provided by Lonza Small Molecules | 04-Apr-2023 | Insight Guide

With the complexities associated with API and HPAPI drug development, it’s necessary to lean on the experts. With Q&A sections, insights and articles...

Related suppliers

Follow us


View more